Zelira Therapeutics Ltd has released a press release.
New Licence Agreement
Filed with ASX ·
6ix hasn’t read this filing yet.
Zelira Therapeutics Ltd. on 6ix
Earlier from Zelira Therapeutics
- Appendix 4D & FY17 Interim Financial Report
- Quarterly Report and Appendix 4C
- Zelda to Test Formulations Against Pancreatic Cancer
- Sleep Disorder Clinical Trials Update
- Collaboration Agreement with Telethon Kids Institute
Later from Zelira Therapeutics
- Clinical Trials to Commence in Chile
- Zelda Enters Strategic Partnership with CannPal
- Zelda Successfully Completes Capital Raising
- Cleansing Prospectus
- Clinical Research Programme to Expand to Include Autism
Follow Zelira Therapeutics into a list and get an email when it puts out news.
Follow Zelira Therapeutics